These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25205484)

  • 1. Overlapping technique for hybrid percutaneous coronary intervention strategy utilising drug eluting stent and ABSORB bioresorbable vascular scaffold.
    Yew KL
    Int J Cardiol; 2015 Jan; 178():e8-e10. PubMed ID: 25205484
    [No Abstract]   [Full Text] [Related]  

  • 2. Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS-DES percutaneous coronary intervention: Method and rationale for hybrid overlapping PCI.
    Yew KL
    Int J Cardiol; 2015; 186():74-6. PubMed ID: 25814348
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter regarding "Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS-DES percutaneous coronary intervention: Method and rationale for hybrid overlapping PCI".
    Granata F; Moscarella E; Varricchio A
    Int J Cardiol; 2015 Jul; 190():7-8. PubMed ID: 25912107
    [No Abstract]   [Full Text] [Related]  

  • 4. Further elucidation on "Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS-DES percutaneous coronary intervention: Method and rationale for hybrid overlapping PCI".
    Yew KL
    Int J Cardiol; 2015 Jul; 191():170-1. PubMed ID: 25965626
    [No Abstract]   [Full Text] [Related]  

  • 5. Subacute recoil in bioresorbable vascular scaffold in a complex coronary lesion: A lesson from daily clinical practice.
    Centola M; Lucreziotti S; Salerno-Uriarte D; Tresoldi S; Cannone G; Sponzilli C; Carugo S
    Int J Cardiol; 2016 Jan; 203():995-6. PubMed ID: 26625328
    [No Abstract]   [Full Text] [Related]  

  • 6. Intracoronary optical coherence tomography and histology of overlapping everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: the potential implications for clinical practice.
    Farooq V; Serruys PW; Heo JH; Gogas BD; Onuma Y; Perkins LE; Diletti R; Radu MD; Räber L; Bourantas CV; Zhang Y; van Remortel E; Pawar R; Rapoza RJ; Powers JC; van Beusekom HM; Garcìa-Garcìa HM; Virmani R
    JACC Cardiovasc Interv; 2013 May; 6(5):523-32. PubMed ID: 23702016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioresorbable scaffold in myocardial infarction: has the time come?
    Karanasos A; Regar E; Geeve P; van Mieghem NM
    Int J Cardiol; 2013 Jul; 167(1):e17-9. PubMed ID: 23558005
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel use of absorb bioresorbable vascular scaffold and STENTYS self-apposing coronary stent for complex saphenous vein grafts intervention.
    Yew KL
    Int J Cardiol; 2014 Dec; 177(3):e184-5. PubMed ID: 25156853
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioresorbable vascular scaffolds for left main lesions; a novel strategy to overcome limitations.
    Miyazaki T; Panoulas VF; Sato K; Naganuma T; Latib A; Colombo A
    Int J Cardiol; 2014 Jul; 175(1):e11-3. PubMed ID: 24845788
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA
    JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.
    Muramatsu T; Onuma Y; van Geuns RJ; Chevalier B; Patel TM; Seth A; Diletti R; García-García HM; Dorange CC; Veldhof S; Cheong WF; Ozaki Y; Whitbourn R; Bartorelli A; Stone GW; Abizaid A; Serruys PW; ; ; ; ; ;
    JACC Cardiovasc Interv; 2014 May; 7(5):482-93. PubMed ID: 24746650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention).
    Taniwaki M; Stefanini GG; Silber S; Richardt G; Vranckx P; Serruys PW; Buszman PE; Kelbaek H; Windecker S;
    J Am Coll Cardiol; 2014 Apr; 63(16):1617-25. PubMed ID: 24530680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioresorbable Stents in PCI.
    Lindholm D; James S
    Curr Cardiol Rep; 2016 Aug; 18(8):74. PubMed ID: 27312934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 16. Short-term outcomes following "full-plastic jacket" everolimus-eluting bioresorbable scaffold implantation.
    Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Naganuma T; Sticchi A; Latib A; Colombo A
    Int J Cardiol; 2014 Dec; 177(2):607-9. PubMed ID: 25443250
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioresorbable drug-eluting stents: an immature technology in need of mature application.
    Byrne RA; Kastrati A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):198-200. PubMed ID: 25616925
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population.
    Costopoulos C; Latib A; Naganuma T; Miyazaki T; Sato K; Figini F; Sticchi A; Carlino M; Chieffo A; Montorfano M; Colombo A
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):E10-5. PubMed ID: 24909303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus-Eluting Magnesium Resorbable Scaffold Implantation in Patients with Acute Myocardial Infarction.
    Ielasi A; Cerrato E; Geraci S; Campo G; Garro N; Leoncini M; Sganzerla P; Granata F; Ruggiero R; Varbella F; Caramanno G; Grigis G; Tespili M
    Cardiology; 2019; 142(2):93-96. PubMed ID: 31079093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
    Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.